Login
← Go Back
Novartis India
NOVARTIND · Retail > Trading · Chairman: C Snook · MD: Sanjay Murdeshwar · Listing date: Nov. 9, 2000 · Employees: 539 · Mumbai · http://www.novartis.in
Stock Price vs Company Growth
1d
0.1%
1w
3.5%
1m
1.5%
3m
10.2%
6m
5.3%
1y
50.9%
all
13.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,024 0.1%
974
1,248
Company Overview
Sales
345 Cr
Growth: -1.4%
Profit after Tax
87.4 Cr
Growth: -3.6%
Small Cap
2,529 Cr
P/E: 28.9x
Industry P/E: 26.6x
Fundamentals
Sales (Cr) ₹ 345
Growth -1.4%
EBITDA 21.1%
P/S 7.3x
Dividend 1.1%
P/E 28.9x
Book Value ₹ 320
PEG Ratio -20.7x
ROE 11.1%
P/B 3.2x
Shareholding Pattern
Institutions
Promoters
Novartis Ag
70.68 %
Others
Atul Limited
1.52 %
Iepf
0.47 %
Llp, Partnership Firm, Directors' Relative
0.14 %
Increase    Decrease    No change
Company Profile Detailed
As a science-based and patient-oriented healthcare company, it strives to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis globally is focused on three divisions with global scale and innovation power - pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
Belongs to (4 Indices)
Investors (7)
abdul.ha...
total
bodies.c...